These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7031983)

  • 1. Stability of prostacyclin in human plasma and whole blood: studies on the protective effect of albumin.
    Orchard MA; Robinson C
    Thromb Haemost; 1981 Oct; 46(3):645-7. PubMed ID: 7031983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of human plasma proteins on stabilisation of platelet anti-aggregatory activity of prostacyclin.
    Mikhailidis DP; Mikhailidis AM; Dandona P
    Ann Clin Biochem; 1982 Jul; 19 (Pt 4)():241-4. PubMed ID: 6181729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nonesterified fatty acids on the stability of prostacyclin activity.
    Mikhailidis DP; Mikhailidis AM; Barradas MA; Dandona P
    Metabolism; 1983 Jul; 32(7):717-21. PubMed ID: 6345992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced prostacyclin survival after fasting-induced elevation of plasma free fatty acids.
    Goodnight SH; Inkeles SB; Kovach NL; Connor WE
    Thromb Haemost; 1985 Aug; 54(2):418-21. PubMed ID: 3909499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the stability of prostacyclin in human, rabbit and rat plasma.
    El Tahir KE; Williams KI; Betteridge DJ
    Prostaglandins Leukot Med; 1983 Feb; 10(2):109-14. PubMed ID: 6342001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of prostaglandin I2 in human blood.
    Pifer DD; Cagen LM; Chesney CM
    Prostaglandins; 1981 Feb; 21(2):165-75. PubMed ID: 7012932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum prostacyclin binding and half-life in normal and hypertensive pregnant women.
    O'Brien WF; Knuppel RA; Saba HI; Angel JL; Benoit R; Bruce A
    Obstet Gynecol; 1989 Jan; 73(1):43-6. PubMed ID: 2642327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of human osteoblast proliferation and phenotypic expression when cultured in human serum.
    Hankey DP; McCabe RE; Doherty MJ; Nolan PC; McAlinden MG; Nelson J; Wilson DJ
    Acta Orthop Scand; 2001 Aug; 72(4):395-403. PubMed ID: 11580129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased stabilization of prostacyclin activity in patients with bone tumors.
    Mehta P; Ostrowski N; Brigmon L
    Cancer Res; 1984 Jul; 44(7):3132-4. PubMed ID: 6373003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of a prostacyclin-like substance into the circulation of dogs by intravenous adenosine 5'-diphosphate.
    Hemker DP; Shebuski RJ; Aiken JW
    J Pharmacol Exp Ther; 1980 Feb; 212(2):246-52. PubMed ID: 6985960
    [No Abstract]   [Full Text] [Related]  

  • 11. Accelerated decomposition of 4-hydroxycyclophosphamide by human serum albumin.
    Kwon CH; Maddison K; LoCastro L; Borch RF
    Cancer Res; 1987 Mar; 47(6):1505-8. PubMed ID: 3815352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological properties of the new stable prostacyclin analogue 3-Oxa-methano-prostaglandin I.
    Yamamoto T; Satoh K; Nishimura T; Horikawa N; Mine T; Hirohashi T; Hara Y
    Arzneimittelforschung; 1994 Apr; 44(4):483-90. PubMed ID: 8011001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transitory failure of ADP to induce platelet aggregation in plasma from a young healthy woman.
    Wennmalm A
    Prostaglandins Med; 1980 May; 4(5):325-8. PubMed ID: 6996016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of prostacyclin-like activity in human plasma-a non-enzymatic mechanism?
    Mikhailidis DP; Mikhailidis AM; Woollard ML; Dandona P
    Clin Sci (Lond); 1982 Feb; 62(2):177-81. PubMed ID: 7032807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A barbourin-albumin fusion protein that is slowly cleared in vivo retains the ability to inhibit platelet aggregation in vitro.
    Marques JA; George JK; Smith IJ; Bhakta V; Sheffield WP
    Thromb Haemost; 2001 Sep; 86(3):902-8. PubMed ID: 11583325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet microaggregates and release of endogenous prostacyclin during the initial phase of haemodialysis.
    Leithner C; Sinzinger H; Silberbauer K; Stummvoll HK
    Proc Eur Dial Transplant Assoc; 1981; 18():122-5. PubMed ID: 7036146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of plasma on the platelet antiaggregatory action of prostacyclin in pregnancy.
    Baker VV; Kort B; Cefalo RC
    Am J Obstet Gynecol; 1987 Apr; 156(4):974-7. PubMed ID: 3107390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperativity of albumin and aggrexons A and B for ADP-induced-aggregation of platelets.
    Inada Y; Okada M; Saito Y; Okamoto H; Matsushima A
    Thromb Haemost; 1980 Feb; 42(5):1557-60. PubMed ID: 7368157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of acute, moderate ethanol consumption on human platelet aggregation in platelet-rich plasma and whole blood.
    Zhang QH; Das K; Siddiqui S; Myers AK
    Alcohol Clin Exp Res; 2000 Apr; 24(4):528-34. PubMed ID: 10798590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High circulating prostacyclin levels in patients with chronic renal insufficiency (author's transl)].
    Carreras LO; Chamone DA; Vermylen J
    Sangre (Barc); 1981; 26(4):427-32. PubMed ID: 7027492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.